SLS BIO Co (XKRX:246250) YoY EBITDA Growth : -4.00% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. SLS BIO Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -4.00%.

SLS BIO Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩62.69.

SLS BIO Co YoY EBITDA Growth Historical Data

The historical data trend for SLS BIO Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co YoY EBITDA Growth Chart

SLS BIO Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

6,263.81

-73.38

208.75

110.97

-35.13

SLS BIO Co Quarterly Data
	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial			-	-	-63.38	-36.03	-4.00

SLS BIO Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

SLS BIO Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(346.578	-	534.227)	/	\| 534.227 \|
=	-35.13 %

SLS BIO Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(62.693	-	65.303)	/	\| 65.303 \|
=	-4.00 %

SLS BIO Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

SLS BIO Co (XKRX:246250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229

Website

http://www.slabs.co.kr

SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines